Skip to content

Safety and Effectiveness of drainage of large amount of abdominal fluid in patients with cirrhosis and kidney damage (a pilot study).

Safety and Efficacy of large volume paracentesis in patients of cirrhosis with ascites and acute kidney injury (a pilot study).

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023598
Enrollment
50
Registered
2020-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: Large Volume paracentesis: 5 litres of Ascitic fluid will be taken out in the patients of cirrhosis with ascites and acute kidney injury Control Intervention1: Patients on standard t

Sponsors

KIIT University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age >18 ,consent giving to participate 2.All consecutive hospitalized patients of cirrhosis with ascites and AKI (all etiologies of cirrhosis will be included) . 3.Diagnosis of the patients will be made on the basis of LFTs, imaging, upper GI endoscopy, ascitic fluid analysis and liver biopsy if needed, 4.Grade 2 & 3 ascites.(international ascites club )2 (2)EASL practice guidelines on management of ascites ,SBP,HRS in cirrhosis ,2010.

Exclusion criteria

Exclusion criteria: 1.Refusal to participate 2.Overt Hepatic Encephalopathy, Active Upper GI Bleed, Chronic Kidney Disease Stage-4, Spontaneous Bacterial Peritonitis, Hepatocellular Carcinoma, Hepatic venous outflow obstruction, HIV, Non Cirrhotic Portal Hypertension, portal venous thrombosis. 3.Ascites due to other causes like tuberculosis, constrictive pericarditis, etc. 4.Pregnancy

Design outcomes

Primary

MeasureTime frame
Decrease Heart rate, decrease in Mean arterial pressure, increased creatinine clearance, increase in urinary output, increase in plasma renin decrease in S. Creatinine Timepoint: All the above parameters will be checked on day 1, day 3, day 5.

Secondary

MeasureTime frame
Changes in Renal resistive indexTimepoint: 5 days

Countries

India

Contacts

Public ContactDr Anirudh Tiwari

Kalinga Institute of Medical sciences

dranirudhtiwari@gmail.com9977962462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026